Molecular Modeling of Human CCR2 Receptor within POPC Lipid Bilayer

被引:0
|
作者
Ahmad Ebadi
Dara Dastan
Mojtaba Azami
Adibe Karimi
Nima Razzaghi-Asl
机构
[1] Hamadan University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
[2] Hamadan University of Medical Sciences,Medicinal Plants and Natural Products Research Center
[3] Hamadan University of Medical Sciences,Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy
[4] Ardabil University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
来源
Structural Chemistry | 2017年 / 28卷
关键词
Homology modeling; Docking; MD simulation; CCR2; Inflammation; INCB3344;
D O I
暂无
中图分类号
学科分类号
摘要
Chemokine receptor 2 (CCR2), a G-protein coupled receptor (GPCR), is a critical target for several inflammatory and autoimmune diseases. The main restriction on designing desirable antagonists against CCR2 is the lack of appropriate crystal structure for this target. In the absence of such experimental data, computational methods triggering structure prediction provide a cost-effective option. Homology modeling has been widely used to explore GPCR structure. Within the present contribution, homology modeling, molecular docking and molecular dynamics (MD) simulation were applied to construct a reliable model for CCR2. In the present contribution, we docked INCB3344, one of the most potent CCR2 inhibitors, into the active site of the CCR2 protein. Subsequently, we studied the dynamic behavior of INCB3344-CCR2 complex in the presence of lipid membrane. Moreover; a detailed molecular mechanism of INCB3344 action has been proposed. It was revealed that Tyr120, His121, Tyr259 and Glu291 formed H-bond interactions with INCB3344 while residues such as Trp98, His202, Thr203 and Thr173 participated in hydrophobic interactions. As a consequence, a reliable homology model of CCR2 could be successfully developed on the basis of CCR5 crystallographic structure. Finally it was found that binding of INCB3344 led to the structural changes in CCR2 that provided more interaction sites. Results of this study may be useful to design further CCR2 inhibiting structures with the aim of developing desirable therapeutic agents.
引用
收藏
页码:849 / 857
页数:8
相关论文
共 50 条
  • [1] Molecular Modeling of Human CCR2 Receptor within POPC Lipid Bilayer
    Ebadi, Ahmad
    Dastan, Dara
    Azami, Mojtaba
    Karimi, Adibe
    Razzaghi-Asl, Nima
    STRUCTURAL CHEMISTRY, 2017, 28 (03) : 849 - 857
  • [2] Homology modeling of human CCR2 receptor
    Rajesh Singh
    M. Elizabeth Sobhia
    Medicinal Chemistry Research, 2011, 20 : 1704 - 1712
  • [3] Homology modeling of human CCR2 receptor
    Singh, Rajesh
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (09) : 1704 - 1712
  • [4] HOMOLOGY MODELING OF CCR2
    Singh, Rajesh
    Chavan, Swapnil
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S129 - S129
  • [5] Characterization of the CCR2 chemokine receptor: Functional CCR2 receptor expression in B cells
    Frade, JMR
    Mellado, M
    del Real, G
    Gutierrez-Ramos, JC
    Lind, P
    Martinez, C
    JOURNAL OF IMMUNOLOGY, 1997, 159 (11): : 5576 - 5584
  • [6] Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor
    Singh, Rajesh
    Sobhia, M. Elizabeth
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2013, 31 (07): : 694 - 715
  • [7] CHARMM Molecular Dynamics of the Blood Group Glycolipids in Popc Lipid Bilayer
    Shin, Jaeki
    Im, Wonpil
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 328A - 328A
  • [8] The CCR2 receptor as a therapeutic target
    Feria, M
    Díaz-González, F
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (01) : 49 - 57
  • [9] Use of modeling and crystallography to understand CCR2 antagonist SAR and receptor binding
    Tebben, Andrew
    Carter, Percy
    Cherney, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [10] CCR2 chemokine receptor and AIDS progression
    Smith, MW
    Carrington, M
    Winkler, C
    Lomb, D
    Dean, M
    Huttley, G
    OBrien, SJ
    NATURE MEDICINE, 1997, 3 (10) : 1052 - 1053